Evidence map›Paper›PMID 41488761›Full record

ArticleFrontiers in toxicology2025

Beyond cytotoxicity: pollutant mixtures elicit unconventional epithelial-fibroblast signaling in a human lung air-liquid interface co-culture model.

Justine Fredoc-Louison, Maëva Cherrière, Bastien Rival, Suzanne De Araujo, Sabine François, Samir Dekali

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justine Fredoc-LouisonBiomedical Research Institute of the Armed Forces (IRBA), EBR Department, Emerging Technological Risks Unit (U.RTE), Brétigny-sur-Orge, France.
Maëva CherrièreBiomedical Research Institute of the Armed Forces (IRBA), EBR Department, Emerging Technological Risks Unit (U.RTE), Brétigny-sur-Orge, France.
Bastien RivalBiomedical Research Institute of the Armed Forces (IRBA), EBR Department, Emerging Technological Risks Unit (U.RTE), Brétigny-sur-Orge, France.
Suzanne De AraujoBiomedical Research Institute of the Armed Forces (IRBA), EBR Department, Emerging Technological Risks Unit (U.RTE), Brétigny-sur-Orge, France.
Sabine FrançoisBiomedical Research Institute of the Armed Forces (IRBA), EBR Department, Emerging Technological Risks Unit (U.RTE), Brétigny-sur-Orge, France.
Samir DekaliBiomedical Research Institute of the Armed Forces (IRBA), EBR Department, Emerging Technological Risks Unit (U.RTE), Brétigny-sur-Orge, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Combined exposures to airborne nanoparticles and acidic gases are plausible during industrial accidents and in military settings involving propellants. Aluminum oxide nanoparticles (Al Methods: Cells were exposed daily for four days, and epithelial viability, barrier integrity, and mediator release were assessed. Conditioned media from exposed cultures were applied to naïve fibroblasts to evaluate proliferation and migration responses. Results: Repeated exposures did not induce cytotoxicity, barrier disruption, or increases in canonical pro-fibrotic or pro-inflammatory mediators such as TGF-β1, CTGF, or IL-8. However, conditioned media from exposed epithelial cells consistently triggered fibroblast activation through non-canonical epithelial-mesenchymal signaling pathways. These effects occurred at sub-toxic exposure levels. Discussion: These findings indicate that early sub-lethal co-exposure to Al

Indexed as

air–liquid interface modelaluminum oxide nanoparticlesfibroblast activationhuman lung epithelial cellshydrogen chloridenon-cytotoxic responseparacrine signalingpollutant mixtures

Identifiers

PMID41488761
PMCPMC12756146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.